A recent study showed that serum IL-17F levels were significantly increased in SS patients and were associated with high levels of autoantibodies and increased EULAR SS disease activity index (ESSDAI), compared to IL-17A, suggesting the possibility of several pathogenetic roles played by different IL-17 family members (232). This evidence concerns the gene IL17A and synovial sarcoma.